Hoertkorn Richard Charles Viatris Inc Transaction History

Hoertkorn Richard Charles

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	SELL	$8.72 - $11.56 $967 - $1,283	-111 Reduced 90.24%	12 $0
Q3 2022 Nov 01, 2022	SELL	$8.48 - $11.13 $407 - $534	-48 Reduced 28.07%	123 $1,000
Q2 2022 Jul 15, 2022	SELL	$9.95 - $12.27 $736 - $907	-74 Reduced 30.2%	171 $2,000
Q1 2022 May 02, 2022	SELL	$9.81 - $15.4 $1,393 - $2,186	-142 Reduced 36.69%	245 $3,000
Q4 2021 Jan 26, 2022	SELL	$12.09 - $14.68 $1,184 - $1,438	-98 Reduced 20.21%	387 $5,000
Q3 2021 Oct 12, 2021	SELL	$13.25 - $15.13 $980 - $1,119	-74 Reduced 13.24%	485 $7,000
Q2 2021 Jul 12, 2021	SELL	$12.97 - $16.15 $959 - $1,195	-74 Reduced 11.69%	559 $8,000
Q1 2021 Apr 21, 2021	SELL	$13.59 - $18.54 $10,464 - $14,275	-770 Reduced 54.88%	633 $9,000
Q4 2020 Jan 29, 2021	BUY	$14.3 - $18.74 $20,062 - $26,292	1,403 New	1,403 $26,000

1,095

930M

2.69M

2.34M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $13.7B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Hoertkorn Richard Charles, based on Form 13F filings with the SEC.

Stay updated on Hoertkorn Richard Charles with notifications on news.